Delivery Order SPE2DB25D3012-SPE2DB25FXAGE
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,067.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count packaging). The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price terms with no set-aside designation. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $8,139.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's existing contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count supply). The contract is valued at $1,444.94 with a firm fixed-price structure and was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,182.88 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valsartan-HCZ 160-25 mg tablets in a quantity of 90 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.93 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets in a 90-count quantity. This is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $3,589.76 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets in quantities of 90 units. The contract, which was competitively awarded without a set-aside designation, was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. This delivery order operates under a firm fixed-price arrangement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) valued at $5,573.64. This is a firm fixed-price delivery order with no set-aside designation, and the product is scheduled for delivery by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,768.94 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 160-25 mg tablets in quantities of 90 per unit. This competitively awarded, non-set-aside contract employs firm fixed price terms with an ultimate completion date of August 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAGEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $23,124.56 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count units) under a firm fixed-price contract. This non-set-aside delivery order, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceuticals and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive federal procurement history and demonstrated capability in fulfilling competitive medical supply requirements positions it as a critical vendor within the Defense Health Agency supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 9/18/25 |